[1] 冯春花. 依达拉奉联合奥扎格雷钠治疗急性进展性脑梗塞疗效观察[J].中国卫生标准管理,2014,5(18):134-136. [2] 尤丽玲. 氯吡格雷对急性脑梗死患者血浆高敏C反应蛋白和血小板膜糖蛋白的影响[J].海峡药学,2012,24(2):178-179. [3] Edaraven Acute Infarction Study Group. Effect of a novel free radical scavenger edaravone (MCI-186),on acute brain inarction.Randomized placebo-controlled double-blind study at multicenters[J].Cerebrovasc Dis,2003,15(3):222-227. [4] 詹三华,张鲁峰,姚卫民,等.依达拉奉联合纤溶酶治疗中老年进展性脑梗死40例疗效观察[J].中国医药导刊,2012,14(5):825-827. [5] Tanaka M.Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent[J].Nihon Yakurigaku Zasshi,2012,119(5):301-308. [6] Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary[J].Control Clin Trials,1996,17(1):1-12. [7] 李文华,刘增香,罗金凤,等.依达拉奉联合氯吡格雷治疗急性脑梗患者疗效及对凝血功能的影响[J].医药前沿,2015,5(22):215-216. [8] 全国第四次脑血管病学术会议.各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379. [9] 全国第四次脑血管病学术会议.脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. [10] Adams HP Jr, Adams RJ, Brott T, et al.Guidelines for the early management of patients with ischemic stroke:A scientific statement from the Stroke Council of the American Stroke Association[J].Stroke,2003,34(4):1056-1083. [11] 杜茜琳. 依达拉奉联合氯吡格雷治疗急性脑梗死40例疗效观察[J].中国医学创新,2012,9(22):122-123. [12] Shishidu T,Suzuki R, Qian L,et al.The role of superoxide anion in the pathogenesis of cerebral vasospasm[J].Stroke, 1994,25(4):864-868. [13] 杨晓云. 氯吡格雷治疗短暂性脑缺血发作临床观察[J].中西医结合心脑血管病杂志,2011,9(9):1147. [14] Peters O,Back T,Lindauer U,et al.Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat[J]. J Cereb Blood Flow Metab, 1998,18(2):196-205. [15] 林美容,李世博,余碧晖,等.依达拉奉对急性脑梗死患者神经功能及血清超敏C反应蛋白水平的影响[J].广东医学,2016,37(z1):214-215. |